|
|
Volumn 4, Issue 3, 2002, Pages 213-221
|
|
New developments in the treatment of esophageal cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CAMPTOTHECIN;
DRUG DERIVATIVE;
IRINOTECAN;
PACLITAXEL;
ESOPHAGUS TUMOR;
HUMAN;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
REVIEW;
SURVIVAL RATE;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CAMPTOTHECIN;
COMBINED MODALITY THERAPY;
ESOPHAGEAL NEOPLASMS;
HUMANS;
PACLITAXEL;
SURVIVAL RATE;
|
|
EID: 0036584228
PISSN: 15233790
EISSN: None
Source Type: Journal
DOI: 10.1007/s11912-002-0018-y Document Type: Review |
|
Times cited : (9)
|
|
References (62)
|
